Menu

Experience

Kristin VanderPas

    • Lavoro to Become Publicly Traded Through Business Combination With TPB Acquisition Corporation I 


    • Erasca – $100 Million Follow-on Offering 


    • Autolus Therapeutics – $150 Million Follow-on Offering 


    • Corsair Gaming – $75 Million Follow-on Offering 


    • LumiraDx Limited – $100.3 Million Follow-on Offering and Concurrent Private Placement 


    • Pliant Therapeutics – $230.0 Million Follow-on Offering 


    • Arcutis Biotherapeutics – $172.5 Million Follow-on Offering 


    • Crinetics Pharmaceuticals – $125 Million Follow-On Offering 


    • Zymeworks – $115 Million Follow-On Offering 


    • Grindr Agrees to Merge With SPAC Tiga Acquisition Corp. 


    • IGM Biosciences – $230 Million Follow-On Offering 


    • Global Blood Therapeutics – $345 Million Convertible Senior Notes Offering 


    • Lulu’s – $92 Million IPO 


    • PROCEPT BioRobotics – $188.5 Million IPO 


    • DICE Therapeutics – $234.6 Million IPO 


    • Erasca – $345 Million IPO 


    • Graphite Bio – $274 Million IPO 


    • Doximity – $697 Million IPO 


    • Singular Genomics Systems – $258 Million IPO 


    • FIGS – $668 Million IPO 


    • Day One Biopharmaceuticals – $184 Million IPO 


    • Treace Medical Concepts – $220 Million IPO 


    • Biomea Fusion – $153 Million IPO 


    • Reneo Pharmaceuticals – $94 Million IPO 


    • Xos Trucks to Combine with NextGen Acquisition Corporation, a Special Purpose Acquisition Company 


    • Canoo to List on Nasdaq Through Hennessy Capital Merger 


    • Acutus Medical – $183 Million IPO 


    • Annexon – $251 Million IPO 


    • ALX Oncology – $186 Million IPO 


    • Hyliion to Combine With Tortoise, a Special Purpose Acquisition Company 


    • Applied Molecular Transport - $177 Million IPO 


    • Pliant Therapeutics - $166 Million IPO 


    • The Underwriters On Guardant Health's $1.1 Billion Follow-On Offering 


    • The Underwriters On Livongo Health's $550 Million Convertible Senior Notes 


    • ORIC Pharmaceuticals - $138 Million IPO 


    • Vir Biotechnology - $143 Million IPO 


    • Exagen Diagnostics – $58 Million IPO  


    • 10X Genomics – $449 Million IPO  


    • Livongo Health - $409 Million IPO 


    • Health Catalyst - $209 Million IPO 


    • Medallia - $374 Million IPO 


    • Mirum Pharmaceuticals - $75 Million IPO 


    • Uber Technologies $8.1 Billion IPO 


    • Precision BioSciences $145 Million IPO 


    • ShockWave Medical – $111 Million IPO 


    • Gossamer Bio – $317 Million IPO 


    • Allogene Therapeutics – $372.6 Million IPO 


    • Gritstone Oncology – $100 Million IPO 


    • Sutro Biopharma – $85 Million IPO 


    • Guardant Health – $273.1 Million IPO 


    • Eidos Therapeutics – $122 Million IPO 


    • Crinetics Pharmaceuticals – $117 Million IPO 


    • Aridis – $26 Million IPO 


    • Gemphire Therapeutics – $30 Million IPO 


    • Tricida – $256 Million IPO 


    • Atlassian - $531 Million IPO 


    • NantKwest IPO - $238 Million IPO 


    • ProNAi Therapeutics - $158 Million IPO 


    • NantKwest – $238 Million IPO 


    • ProNAi – $158 Million IPO 


    • MINDBODY Completes $100 Million IPO 


    • MINDBODY Completes $100 Million IPO 


    • FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes 


    • FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes 


    • Apigee Completes Initial Public Offering 


    • InsideSales.com Tops $200 Million in Capital with Latest $60 Million Round 


    • Invitae Completes $117 Million Initial Public Offering  


    • Ascendis Pharma closes $124 million IPO 


    • TRACON Pharmaceuticals Completes Initial Public Offering 


    • Cooley Advises Xencor on its Initial Public Offering 


    • Xenon Pharmaceuticals Completes Initial Public Offering 


    • Demira Prices $125 Million IPO 


    • Otonomy $100 Million IPO 


    • Immune Design $63 Million Initial Public Offering 


    • HealthEquity $146 Million Initial Public Offering 


    • Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering 


    • Minerva Neurosciences $32.7 Million IPO 


    • Kite Pharma $146 Million Initial Public Offering 


    • Vital Therapies Initial Public Offering 


    • Cooley Advises Underwriters on Vital Therapies IPO 


    • Amedica Initial Public Offering 


    • Celladon Initial Public Offering 


    • Xencor Initial Public Offering 


    • Five Prime Therapeutics IPO 


    • Receptos, Inc. Initial Public Offering 


    • Sana Biotechnology - $676 million IPO 


    • 4D Molecular Therapeutics - $222 million IPO 


    • AbCellera Biologics - $556 million IPO 


    • Olema - $240 million IPO 


    • Spruce Biosciences – $130 Million IPO 


    • Arcutis – $192.5 Million Follow-On Offering 


    • Ventyx Biosciences – $174.3 Million IPO 


    • Qualtrics International – $1.15 Billion Follow-On Offering